GO Therapeutics appoints Dr. Robert J. Wills to Board of Directors
October 04, 2017 07:30 ET
|
GO Therapeutics
CAMBRIDGE, Mass., Oct. 04, 2017 (GLOBE NEWSWIRE) -- GO Therapeutics, a company exploiting new advances in glycoproteomics to develop novel, multimodal first-in-class cancer therapeutics against...
Salubris Pharmaceuticals Invests $5 Million in GO Therapeutics
September 25, 2017 12:06 ET
|
GO Therapeutics
CAMBRIDGE, Mass., Sept. 25, 2017 (GLOBE NEWSWIRE) -- GO Therapeutics today announced that Salubris Pharmaceutical Limited has made a $5M investment in GO Therapeutics, a Cambridge, MA-based company...